A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/695 (2006.01) A61K 9/02 (2006.01) A61K 9/12 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01) A61K 31/395 (2006.01) A61K 31/403 (2006.01) A61K 31/404 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61K 31/5377 (2006.01) A61K 31/655 (2006.01) A61K 31/66 (2006.01) A61K 38/48 (2006.01) A61K 45/06 (2006.01) A61P 31/00 (2006.01)
Patent
CA 2358492
The present invention provides a method of prevention and treatment for sepsis for mammals. Said treatment is a combination therapy of Activated Protein C and an sPLA2 inhibitor.
La présente invention se rapporte à un procédé de prévention et de traitement de la septicémie chez les mammifères. Ledit traitement est une polythérapie combinant la protéine C activée et un inhibiteur de sPLA¿2? (phospholipase de sécrétion non pancréatique A¿2?).
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Combination therapy for the treatment of sepsis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy for the treatment of sepsis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for the treatment of sepsis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2078825